MYNX CONTROL VENOUS Vascular Closure Device

Name: Cordis
Price range: $

Move Foward with MYNX CONTROL^™ VENOUS Vascular Closure Device (VCD), achieving the fastest time to hemostasis.

Request Additional Information

Move Forward With MYNX

DESIGNED FOR EASY AND CONFIDENT DEPLOYMENT

MYNX CONTROL VENOUS VCD is designed to pair procedural simplicity with enhanced safety & reliability.

ACHIEVES QUICKEST TIME TO HEMOSTASIS

Save valuable staff time and move your patients to a quick recovery and on average eligible to discharge within 3 hours^1-3.

RESORBS 3X FASTER THAN COLLAGEN SEALANTS

Quick and consistent resorption within 30 days, leaving nothing behind to impede future re-access^1,4.

Designed For Easy and Confident Deployment

Sealant Protection

- Minimizes sealant expansion inside cannula
- Facilitates smooth deployment

Sheath Catch

- Sized to accommodate 6F-12F sheath ID (Inner Diameter)
(Note: Use only with a standard sheath introducer with up to 12 cm effective length. Incompatible with Cook Check-Flo^™ Performer^™ Introducer)

Tension Indicator

- Prevents vessel tenting allowing for a more consistent seal
- Provides confirmation of correct deployment position

Two-Button Design

- Ergonomic handle and buttons for a simple and easy deployment

Clinical Highlights: ReliaSeal Study Recap

MYNX CONTROL VENOUS ReliaSeal Study Recap

This is a brief interview with Dr. Gupta, Saint Luke's Cardiovascular Consultants, Kansas City, MO after his Abstract Presentation at TCT 2024 presenting the ReliaSeal Study results.

Achieves Quickest Time To Hemostasis (TTH)

The ReliaSeal Study* demonstrates significantly less time to hemostasis (TTH) compared to manual compression, while also showing the least mean TTH in a cross-trial comparison of venous closure methods.

_*_{https://clinicaltrials.gov/study/NCT05554471}

Data is based on a cross-trial comparison and not head-to-head clinical trials, the data may not be directly comparable due to differences in study protocols, conditions and patient populations.

Discharge Patients Faster

The ReliaSeal Study* demonstrated statistically and clinically significant time to ambulation (TTA) and time to discharge eligibility (TTDE) compared to patients treated with manual compression.

_*_{https://clinicaltrials.gov/study/NCT05554471}

Proven Results

The ReliaSeal Study* demonstrated 100% procedural and device success, as well as 0% minor or major access site complications.

_*_{https://clinicaltrials.gov/study/NCT05554471}

Resorbs 3X Faster Than Collagen Sealants

GRIP TECHNOLOGY™ is made of a hydrophilic, bio-inert polyethylene glycol (PEG)^1,4.

Promotes Natural Vessel Healing
Helps to minimize access site infections
Quick and consistent resorption within 30 days¹

Procedural Use

Deploying The Balloon

Achieve temporary hemostasis and position at the venotomy.

Place The Sealant

The Grip Tip securely adheres to the vein and Sealant fills the tissue tract. Expands to 3–4 times its original size on contact with blood and subcutaneous fluids, creating a matrix structure for clot formation.

Remove The Device

Achieve secure, extravascular closure with nothing left behind to impede re-access.

The Final Result

The sealant dissolves within 30 days leaving nothing behind but a healed vein.

Vascular Closure Going Beyond